SCHEMBL17876304

SCHEMBL17876304

c1ccc(N2Cc3ccc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)cc3-c3cc(-c4ccc5oc6ccccc6c5c4)ccc3C2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.38
PIM2 Q9P1W9 2/20 0.38
PIM3 Q86V86 1/20 0.38
CYP1A2 P05177 4/20 0.38
CYP3A4 P08684 3/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
PGR P06401 1/20 0.38
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
BTK Q06187 3/20 0.37
PIK3CD O00329 2/20 0.37
PIK3CA P42336 2/20 0.37
PIK3CB P42338 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876245 0.96 CYP11B1 (0.37) PIM1PIM2PIM3CYP1A2CYP3A4
SCHEMBL17876268 0.96 CYP11B1 (0.37) PIM1PIM2PIM3CYP1A2CYP3A4
SCHEMBL17876298 0.94 CYP11B1 (0.38) PIM1PIM2PIM3CYP1A2ALDH1A1
SCHEMBL17876266 0.90 CYP11B1 (0.37) PIM1PIM2PIM3CYP1A2CYP3A4
SCHEMBL17876240 0.90 CYP11B1 (0.37) PIM1PIM2PIM3CYP1A2CYP3A4
SCHEMBL17876303 0.89 PRKDC (0.42) ALDH1A1LMNAMAPK1MEN1KMT2A
SCHEMBL17876311 0.89 ALK (0.36) PIM1PIM2PIM3CYP1A2CYP3A4
SCHEMBL17876295 0.88 ALOX5 (0.42) PIM1PIM2PIM3PGRCYP11B1
SCHEMBL17876301 0.87 MAPT (0.40) CYP1A2ALDH1A1LMNAMAPK1MEN1
SCHEMBL17876310 0.87 CYP11B2 (0.48) PIM1PIM2PIM3CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PIM1 3767/4885PIM2 4398/4885PIM3 3628/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PIM1 3767/4885PIM2 4398/4885PIM3 3628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.